ACTIVE_NOT_RECRUITING

Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A single arm, pilot study in which all eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.

Official Title

Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms

Quick Facts

Study Start:2024-01-01

Study Completion:2025-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06216691

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* • Adults aged 18 years of age and older * Dermatologist confirmed diagnosis of psoriasis * Current depression symptoms, defined as a PHQ-9 score of 5 or greater * Current psoriasis symptoms, defined as a scaled score of "mild" on any of the Skindex-16 subscales * Participants must be proficient in English and have access to an Android or iOS smartphone	* Previous participation in CBT for depression * Current participation in any type of psychotherapy * Those on psychotropic medications must be taking a stable dose for 2 months prior to enrollment and be willing to remain at a stable dose during the 8-week study * Current elevated suicide risk (see Section 5.3 for details) * Individuals who are incarcerated or compulsory detained * Any uncontrolled or poorly controlled chronic medical condition that may interfere with an individual's ability to participate in the clinical trial

Inclusion Criteria

Exclusion Criteria

* • Adults aged 18 years of age and older
* Dermatologist confirmed diagnosis of psoriasis
* Current depression symptoms, defined as a PHQ-9 score of 5 or greater
* Current psoriasis symptoms, defined as a scaled score of "mild" on any of the Skindex-16 subscales
* Participants must be proficient in English and have access to an Android or iOS smartphone

* Previous participation in CBT for depression
* Current participation in any type of psychotherapy
* Those on psychotropic medications must be taking a stable dose for 2 months prior to enrollment and be willing to remain at a stable dose during the 8-week study
* Current elevated suicide risk (see Section 5.3 for details)
* Individuals who are incarcerated or compulsory detained
* Any uncontrolled or poorly controlled chronic medical condition that may interfere with an individual's ability to participate in the clinical trial

Contacts and Locations

Study Locations (Sites)

Brigham and Women's Hospital

Boston, Massachusetts, 02115

United States

Collaborators and Investigators

Sponsor: Brigham and Women's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-01

Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-01-01

Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

Psoriasis
Depressive Symptoms